By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

LabToWallStreet 



New York City  New York    U.S.A.
Phone: 917-335-2065 Fax:


SEARCH JOBS
LabToWallStreet is a quarterly publication and web property dedicated to the growing life sciences industry and culture in New York City, New York State, and the Tri-State area. Our goal is to enhance connectivity amongst the "value-added constituencies" of the Tri-State life sciences industry by providing critical and valuable information, while promoting the outstanding science and resources of the region to the global life sciences community.

Each issue is a compilation of regular columns, addressing local development efforts and companies, as well as feature article(s) that speak to a specific topic of relevance to the pharmaceutical/ biotechnology industry, framed through the scope of business activity in the Tri-State area. Our authors and contributors are members of the industry, who experience the passion and daily grind of the business first-hand, bringing that insight to life in the pages of LabToWallStreet.

Members of the LabToWallStreet community are found on every continent and are considered leaders in the world of life sciences. They include: Venture Capitalists (corporate & financial), Biotech C-level Executives (CEO, CSO, CFO, CBO, CIO), Biotech and Pharma VP-level Executives, Licensing Managers, Business Development Professionals, Technology Transfer Directors/Managers, Investment Bankers (Managing Directors, VP, Associates), IP Attorneys, Domestic and International Government Officials, and professionals in Academia and Research.

Primary Contacts:

Craig A. Kasper, Au.D. - Chief Creative Officer, Chairman & Founder
ckasper@labtowallstreet.com

Matthew L. Wotiz - Chief Executive Officer & Founder
mwotiz@labtowallstreet.com

Last Updated: 08-30-05


Key Statistics


Email:
Ownership: Private

Web Site: LabToWallStreet
Employees:
Symbol: 
 



Industry
Services

Segment
Publications





Company News
Currently No News Articles
//-->